×
About 2,220 results

ALLMedicine™ Central Retinal Vein Occlusion Center

Research & Reviews  1,069 results

Tractional retinal detachment ('crunch' phenomenon) from intravitreal anti-vascular end...
https://doi.org/10.1136/bcr-2020-240506
BMJ Case Reports; Bromeo AJ, Veloso A et. al.

Apr 29th, 2021 - Tractional retinal detachment is an uncommon complication of intravitreal anti-vascular endothelial growth factor (VEGF) injection wherein the drug triggers tractional retinal detachment as a result of fibrovascular membrane contraction. We presen...

Central retinal vein occlusion and compressive optic neuropathy secondary to thyroid ey...
https://doi.org/10.1017/cjn.2021.85
The Canadian Journal of Neurological Sciences. Le Journal... Jeeva-Patel T, Emami S et. al.

Apr 29th, 2021 - Central retinal vein occlusion and compressive optic neuropathy secondary to thyroid eye disease.|2021|Jeeva-Patel T,Emami S,Margolin E,|

AQUEOUS HUMOR CYTOKINE LEVELS AND REBOUND MACULAR EDEMA AFTER CONBERCEPT TREATMENT IN P...
https://doi.org/10.1097/IAE.0000000000002918
Retina (Philadelphia, Pa.); Yang KB, Sun XY et. al.

Mar 23rd, 2021 - This study aimed to investigate the effect of intravitreal conbercept (IVC) injections on the aqueous humor concentrations of angiogenic and inflammatory cytokines in patients with macular edema (ME) due to central retinal vein occlusion and to de...

Photocoagulation for retinal vein occlusion.
https://doi.org/10.1016/j.preteyeres.2021.100964
Progress in Retinal and Eye Research; Hayreh SS

Mar 13th, 2021 - The role of photocoagulation in retinal vein occlusion (RVO) has been studied since 1974. The most serious complications of central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO) are: (i) visual deterioration, most commonly...

Real-Life Management of Central and Branch Retinal Vein Occlusion: A Seven-Year Follow-...
https://doi.org/10.1055/s-0041-1725197
Thrombosis and Haemostasis; Arrigo A, Crepaldi A et. al.

Mar 11th, 2021 - Retinal vein occlusion is the second most common retinal vascular pathology after diabetic retinopathy and a major cause of vision impairment. Nowadays, both central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO) can be wel...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  1,113 results

Tractional retinal detachment ('crunch' phenomenon) from intravitreal anti-vascular end...
https://doi.org/10.1136/bcr-2020-240506
BMJ Case Reports; Bromeo AJ, Veloso A et. al.

Apr 29th, 2021 - Tractional retinal detachment is an uncommon complication of intravitreal anti-vascular endothelial growth factor (VEGF) injection wherein the drug triggers tractional retinal detachment as a result of fibrovascular membrane contraction. We presen...

Central retinal vein occlusion and compressive optic neuropathy secondary to thyroid ey...
https://doi.org/10.1017/cjn.2021.85
The Canadian Journal of Neurological Sciences. Le Journal... Jeeva-Patel T, Emami S et. al.

Apr 29th, 2021 - Central retinal vein occlusion and compressive optic neuropathy secondary to thyroid eye disease.|2021|Jeeva-Patel T,Emami S,Margolin E,|

AQUEOUS HUMOR CYTOKINE LEVELS AND REBOUND MACULAR EDEMA AFTER CONBERCEPT TREATMENT IN P...
https://doi.org/10.1097/IAE.0000000000002918
Retina (Philadelphia, Pa.); Yang KB, Sun XY et. al.

Mar 23rd, 2021 - This study aimed to investigate the effect of intravitreal conbercept (IVC) injections on the aqueous humor concentrations of angiogenic and inflammatory cytokines in patients with macular edema (ME) due to central retinal vein occlusion and to de...

Photocoagulation for retinal vein occlusion.
https://doi.org/10.1016/j.preteyeres.2021.100964
Progress in Retinal and Eye Research; Hayreh SS

Mar 13th, 2021 - The role of photocoagulation in retinal vein occlusion (RVO) has been studied since 1974. The most serious complications of central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO) are: (i) visual deterioration, most commonly...

Real-Life Management of Central and Branch Retinal Vein Occlusion: A Seven-Year Follow-...
https://doi.org/10.1055/s-0041-1725197
Thrombosis and Haemostasis; Arrigo A, Crepaldi A et. al.

Mar 11th, 2021 - Retinal vein occlusion is the second most common retinal vascular pathology after diabetic retinopathy and a major cause of vision impairment. Nowadays, both central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO) can be wel...

see more →

News  37 results

FDA Okays Aflibercept (Eylea) for Diabetic Retinopathy
https://www.staging.medscape.com/viewarticle/913006

May 13th, 2019 - The US Food and Drug Administration (FDA) has approved aflibercept (Eylea, Regeneron Pharmaceuticals) injection solution to treat all stages of diabetic retinopathy, the manufacturer has announced. Aflibercept, a vascular endothelial growth factor...

FDA OKs Aflibercept (Eylea) for Diabetic Retinopathy
https://www.medscape.com/viewarticle/913006

May 13th, 2019 - The US Food and Drug Administration (FDA) has approved aflibercept (Eylea, Regeneron) injection solution to treat all stages of diabetic retinopathy, the manufacturer has announced. Aflibercept, a vascular endothelial growth factor (VEGF) inhibito...

Despite Significantly Different Pricing, Similar Efficacy for Key Anti-VEGF Agents in Macular Edema
https://www.medscape.com/viewarticle/881454

Jun 19th, 2017 - Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial Scott IU, VanVeldhuisen PC, Ip MS, et al; SCORE2 Investigator Group JAMA. 2017; 317...

Bevacizumab Effective for Macular Edema Due to Central Retinal Vein Occlusion
https://www.staging.medscape.com/viewarticle/879930

May 14th, 2017 - NEW YORK (Reuters Health) - Bevacizumab is as effective as aflibercept for improving visual acuity in patients with macular edema due to central retinal vein occlusion, according to results from the SCORE2 trial. “Although aflibercept has been dem...

Bevacizumab Effective for Macular Edema Due to Central Retinal Vein Occlusion
https://www.medscape.com/viewarticle/879930

May 14th, 2017 - NEW YORK (Reuters Health) - Bevacizumab is as effective as aflibercept for improving visual acuity in patients with macular edema due to central retinal vein occlusion, according to results from the SCORE2 trial. “Although aflibercept has been dem...

see more →